{ "cik": 1710340, "cik_padded": "0001710340", "entityName": "Eton Pharmaceuticals, Inc.", "fiscal_years": [ { "accn": "0001437749-26-009059", "filed": "2026-03-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 333000.0, "cash": 25942000.0, "cost_of_revenue": 37210000.0, "free_cash_flow": 10191000.0, "gross_profit": 42740000.0, "net_income": -4601000.0, "operating_cash_flow": 10524000.0, "operating_income": -844000.0, "revenue": 79950000.0, "stockholders_equity": 26154000.0, "total_assets": 92114000.0, "total_liabilities": 65960000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5345841150719199, "leverage": 2.5219851647931484, "net_margin": -0.05754846779237023, "operating_margin": -0.010556597873671046, "revenue_growth_yoy": 1.0494219579093076, "roa_avg2y": -0.05469664818084012, "roa_period_end": -0.04994897626853681, "roe_avg2y": -0.1819224229963228, "roe_period_end": -0.1759195534143917 } }, { "accn": "0001437749-26-009059", "filed": "2026-03-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 26000.0, "cash": 14936000.0, "cost_of_revenue": 15600000.0, "free_cash_flow": 943000.0, "gross_profit": 23411000.0, "net_income": -3823000.0, "operating_cash_flow": 969000.0, "operating_income": -2597000.0, "revenue": 39011000.0, "stockholders_equity": 24428000.0, "total_assets": 76123000.0, "total_liabilities": 51695000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6001127887006229, "leverage": 2.1162190928442772, "net_margin": -0.0979980005639435, "operating_margin": -0.06657096716310784, "revenue_growth_yoy": 0.23288666961633273, "roa_avg2y": -0.07088621677498308, "roa_period_end": -0.05022135228511751, "roe_avg2y": -0.19160506202230296, "roe_period_end": -0.15650073685934174 } }, { "accn": "0001437749-26-009059", "filed": "2026-03-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 21388000.0, "cost_of_revenue": 10581000.0, "free_cash_flow": 6815000.0, "gross_profit": 21061000.0, "net_income": -936000.0, "operating_cash_flow": 6815000.0, "operating_income": -1192000.0, "revenue": 31642000.0, "stockholders_equity": 15477000.0, "total_assets": 31740000.0, "total_liabilities": 16263000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.665602679982302, "leverage": 1.0507850358596627, "net_margin": -0.029580936729663106, "operating_margin": -0.03767144933948549, "revenue_growth_yoy": 0.48896522516587454, "roa_avg2y": -0.03297516293817157, "roa_period_end": -0.029489603024574665, "roe_avg2y": -0.06555769567501313, "roe_period_end": -0.060476836596239585 } }, { "accn": "0001437749-26-009059", "filed": "2026-03-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 38000.0, "cash": 16305000.0, "cost_of_revenue": 6933000.0, "free_cash_flow": 4783000.0, "gross_profit": 14318000.0, "net_income": -9021000.0, "operating_cash_flow": 4821000.0, "operating_income": -8260000.0, "revenue": 21251000.0, "stockholders_equity": 13078000.0, "total_assets": 25030000.0, "total_liabilities": 11952000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6737565291045128, "leverage": 0.9139012081358006, "net_margin": -0.4244976706978495, "operating_margin": -0.3886875911721802, "revenue_growth_yoy": -0.026612312202271893, "roa_avg2y": -0.343689875226212, "roa_period_end": -0.36040751098681584, "roe_avg2y": -0.5875341930441579, "roe_period_end": -0.6897843706988838 } }, { "accn": "0001493152-23-007933", "filed": "2024-03-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9000.0, "cash": 14406000.0, "cost_of_revenue": 2827000.0, "free_cash_flow": -4730000.0, "gross_profit": 19005000.0, "net_income": -1955000.0, "operating_cash_flow": -4721000.0, "operating_income": -1495000.0, "revenue": 21832000.0, "stockholders_equity": 17630000.0, "total_assets": 27465000.0, "total_liabilities": 9835000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8705111762550385, "leverage": 0.5578559273964833, "net_margin": -0.08954745327958959, "operating_margin": -0.06847746427262734, "revenue_growth_yoy": 558.7948717948718, "roa_avg2y": -0.07269820020824037, "roa_period_end": -0.07118150373202257, "roe_avg2y": -0.11089052750992626, "roe_period_end": -0.11089052750992626 } }, { "accn": "0001493152-23-007933", "filed": "2025-03-18", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 50000.0, "cash": 21295000.0, "cost_of_revenue": 436000.0, "free_cash_flow": -22396000.0, "gross_profit": -397000.0, "net_income": -27970000.0, "operating_cash_flow": -22346000.0, "operating_income": -27111000.0, "revenue": 39000.0, "stockholders_equity": 17630000.0, "total_assets": 26319000.0, "total_liabilities": 10656000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": -10.179487179487179, "leverage": 0.6044242768009075, "revenue_growth_yoy": -0.959332638164755, "roa_avg2y": -1.289207439330737, "roa_period_end": -1.0627303468976785, "roe_avg2y": -1.985095812633073, "roe_period_end": -1.5865002836074873 } }, { "accn": "0001493152-23-007933", "filed": "2023-03-16", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1096000.0, "cash": 12066000.0, "cost_of_revenue": 453000.0, "free_cash_flow": -19122000.0, "gross_profit": 506000.0, "net_income": -18320000.0, "operating_cash_flow": -18026000.0, "operating_income": -18601000.0, "revenue": 959000.0, "stockholders_equity": 10550000.0, "total_assets": 17072000.0, "total_liabilities": 6522000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5276329509906152, "leverage": 0.6181990521327014, "roa_avg2y": -0.8070662349390956, "roa_period_end": -1.0731021555763824, "roe_avg2y": -0.9942202805741731, "roe_period_end": -1.7364928909952608 } }, { "accn": "0001493152-22-006990", "filed": "2022-03-16", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 236000.0, "cash": 26735000.0, "free_cash_flow": -8381000.0, "net_income": -12740000.0, "operating_cash_flow": -8145000.0, "operating_income": -10321000.0, "stockholders_equity": 26303000.0, "total_assets": 28327000.0, "total_liabilities": 2024000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07694939740713987, "roa_avg2y": -0.6100071821881733, "roa_period_end": -0.44974759063790726, "roe_avg2y": -1.3114416593751608, "roe_period_end": -0.4843553967228073 } }, { "accn": "0001493152-21-006122", "filed": "2021-03-16", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 13156000.0, "stockholders_equity": -6874000.0, "total_assets": 13443000.0, "total_liabilities": 1313000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001437749-26-009059", "filed": "2026-03-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001710340.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001710340.json" }, "ticker": "ETON" }